Sartorius Stedim Biotech Stock OTC Markets
Stocks
SDMHF
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Real-time
OTC Markets
12:05:56 2026-04-23 EDT
|
5-day change | 1st Jan Change | ||
| 187.00 USD | +1.30% |
|
-13.86% | -23.99% |
| 08-20 | UBS Upgrades Sartorius Stedim Biotech to Buy, Boosts PT | MT |
| 08-20 | European stock markets slip as oil prices surge again |  |
| Market Cap | 19.24B 22.34B 18.06B 16.49B 30.97B 2,126B 31.19B 214B 83.27B 1,078B 83.88B 82.06B 3,569B | P/E 2026 * |
50.7x | P/E 2027 * | 39.3x |
|---|---|---|---|---|---|
| Enterprise Value | 21.25B 24.68B 19.95B 18.21B 34.21B 2,348B 34.45B 236B 91.97B 1,191B 92.65B 90.63B 3,942B | EV / Sales 2026 * |
6.8x | EV / Sales 2027 * | 6.05x |
| Free-Float |
28.47% | Yield 2026 * |
0.42% | Yield 2027 * | 0.51% |
Last Transcript : Sartorius Stedim Biotech
| 1 day | +1.30% | ||
| 1 week | -13.86% | ||
| Current month | -3.11% | ||
| 1 month | -3.11% | ||
| 3 months | -9.19% | ||
| 6 months | -14.78% | ||
| Current year | -23.99% |
| 1 week | 187 |  | 229 |
| 1 month | 187 | | 229 |
| Current year | 178.3 | | 264.3 |
| 1 year | 178.3 | | 264.3 |
| 3 years | 158 | | 299.86 |
| 5 years | 158 | | 653 |
| 10 years | 60.06 | | 653 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 2025-03-24 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.30% | -13.86% | - | - | 22.32B | |
| -1.73% | -5.23% | -15.89% | +7.45% | 195B | |
| -0.49% | -2.43% | -2.88% | +11.22% | 117B | |
| +0.45% | -0.11% | +9.69% | +83.79% | 61.45B | |
| -0.47% | -1.27% | +0.09% | -32.61% | 51.62B | |
| +0.80% | -1.18% | +27.79% | +52.56% | 51.03B | |
| -0.28% | -0.57% | +21.86% | -10.34% | 34.27B | |
| -1.03% | +0.99% | - | - | 30.95B | |
| +1.00% | -3.47% | +39.93% | -16.18% | 23.75B | |
| -0.91% | -2.06% | -5.54% | +16.29% | 23.41B | |
| Average | -0.14% | -1.35% | +9.38% | +14.02% | 65.32B | |
| Weighted average by Cap. | -0.60% | -1.95% | +0.28% | +15.35% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.63B 2.94B 2.68B 5.03B 345B 5.07B 34.78B 13.53B 175B 13.63B 13.34B 580B | 3.47B 4.03B 3.26B 2.97B 5.58B 383B 5.62B 38.59B 15.01B 194B 15.12B 14.79B 643B |
| Net income | 379M 440M 356M 325M 610M 41.89B 615M 4.22B 1.64B 21.24B 1.65B 1.62B 70.33B | 481M 559M 452M 412M 774M 53.15B 780M 5.35B 2.08B 26.95B 2.1B 2.05B 89.24B |
| Net Debt | 2.01B 2.33B 1.89B 1.72B 3.24B 222B 3.26B 22.36B 8.7B 113B 8.76B 8.57B 373B | 1.76B 2.05B 1.65B 1.51B 2.84B 195B 2.86B 19.6B 7.62B 98.7B 7.68B 7.51B 327B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
- SDMHF Stock
Select your edition
All financial news and data tailored to specific country editions
